Compare Norfolk Southern Corporation (NSC) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Norfolk Southern Corporation vs TransMedics Group Inc — how do they compare? Norfolk Southern Corporation trades at $317.79 (market cap $71.20B), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: Norfolk Southern Corporation is far larger — about 26× TransMedics Group Inc's market cap, and Norfolk Southern Corporation pays a 1.7% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Norfolk Southern Corporation for 33 Days and TransMedics Group Inc for 24 Days on average.
| NSC | TMDX | |
|---|---|---|
Market Cap | $71.20B | $2.74B |
Volume | 555,248 | 949,331 |
Sector | Industrials | Health |
52-Week High | $352.98 | $150.42 |
52-Week Low | $278.19 | $61.99 |
Typical Hold Time | 33 Days | 24 Days |
Enterprise Value | $86.75B | $3.13B |
Dividend Yield | 1.7% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Norfolk Southern (NSC) trades at $317.79, up 1.47% on the day, with a bullish technical signal from moving averages. The company has beaten earnings estimates for the last three quarters, with Q3 2026 results expected on October 22, 2026. Fundamentals show strong profitability with a 21.02% net income margin and 16.97% ROE, though revenue growth is modest. The proposed merger with Union Pacific is a key development, gaining regulatory and customer support.
The outlook is positive, supported by earnings momentum and merger potential, offering upside to the $361.86 consensus price target. Risks include merger approval uncertainty, fuel cost pressures noted in September 2026, and a high P/E ratio of 27.05. Institutional interest remains strong, with recent investments from firms like Bank of America.
TransMedics Group (TMDX) trades at $77.87, down 3.95% on the day, amid a bearish technical signal and recent earnings misses. The company maintains strong profitability with a 22.69% net income margin and 36.28% ROE, though 2026 projections show margin compression. Analyst consensus remains bullish with a $99.75 price target, but sentiment is clouded by multiple legal investigations into fiduciary duties announced in late August and September 2026.
The stock faces near-term pressure from technical weakness and legal overhangs, but solid fundamentals and analyst conviction suggest long-term potential if execution improves. Key risks include ongoing legal scrutiny, margin pressures from heavy investment, and volatility around future earnings reports.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Norfolk Southern Corporation
Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.
Read more on NSC →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
